CCM
Chiron Capital Management Portfolio holdings
AUM
$115M
This Quarter Return
+1.12%
1 Year Return
+10.94%
3 Year Return
+16.4%
5 Year Return
+25.95%
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(-6.2%)
Cap. Flow
-$6.71M
Cap. Flow
% of AUM
-6.33%
Top 10 Holdings %
Top 10 Hldgs %
45.08%
Holding
133
New
14
Increased
32
Reduced
59
Closed
20
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.57M |
| 2 |
Crown Castle
CCI
|
$1.08M |
| 3 |
Amazon
AMZN
|
$868K |
| 4 |
Humana
HUM
|
$762K |
| 5 |
Merck
MRK
|
$659K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.98M |
| 2 |
Nike
NKE
|
$1.04M |
| 3 |
RTX Corp
RTX
|
$885K |
| 4 |
NextEra Energy, Inc.
NEE
|
$869K |
| 5 |
Energy Transfer Partners
ET
|
$803K |
Sector Composition
| 1 | Healthcare | 31.85% |
| 2 | Consumer Discretionary | 8.59% |
| 3 | Financials | 8.19% |
| 4 | Technology | 7.71% |
| 5 | Communication Services | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $23.2M | 21.86% |
409,528
-35,078
| -8% | -$1.98M |
|
2
SPDR S&P Biotech ETF
XBI
$5.07B
| $7.85M | 7.41% |
87,202
-1,703
| -2% | -$153K |
|
3
Apple
AAPL
$3.45T
| $2.76M | 2.6% |
11,010
+1,217
| +12% | +$305K |
|
4
Aflac
AFL
$57.2B
| $2.41M | 2.27% |
23,258
| – | – |
|
5
Enterprise Products Partners
EPD
$69.6B
| $2.19M | 2.06% |
69,717
-1,142
| -2% | -$35.8K |
|
6
Gilead Sciences
GILD
$140B
| $2.11M | 1.99% |
22,874
-6,003
| -21% | -$555K |
|
7
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.23B
| $1.98M | 1.87% |
82,837
+2,334
| +3% | +$55.9K |
|
|
8
Nike
NKE
$114B
| $1.83M | 1.73% |
24,222
-13,740
| -36% | -$1.04M |
|
9
FT Vest SMID Rising Dividend Achievers Target Income ETF
SDVD
$589M
| $1.82M | 1.72% |
84,805
+1,023
| +1% | +$22K |
|
|
10
Amazon
AMZN
$2.44T
| $1.64M | 1.54% |
7,457
+3,955
| +113% | +$868K |
|
11
Pfizer
PFE
$141B
| $1.6M | 1.51% |
60,295
-7,975
| -12% | -$212K |
|
12
Medtronic
MDT
$119B
| $1.59M | 1.5% |
19,852
+3,447
| +21% | +$275K |
|
|
13
NVIDIA
NVDA
$4.24T
| $1.57M | 1.48% |
+11,696
| New | +$1.57M |
|
|
14
Crown Castle
CCI
$43.2B
| $1.55M | 1.47% |
17,125
+11,918
| +229% | +$1.08M |
|
15
Sherwin-Williams
SHW
$91.2B
| $1.36M | 1.29% |
4,006
-2
| -0% | -$680 |
|
16
Raymond James Financial
RJF
$33.8B
| $1.34M | 1.27% |
8,650
| – | – |
|
|
17
Energy Transfer Partners
ET
$60.8B
| $1.34M | 1.27% |
68,436
-40,970
| -37% | -$803K |
|
18
McDonald's
MCD
$224B
| $1.2M | 1.14% |
4,154
-404
| -9% | -$117K |
|
19
AT&T
T
$209B
| $1.19M | 1.12% |
52,340
-21,570
| -29% | -$491K |
|
20
First Trust Enhanced Short Maturity ETF
FTSM
$6.16B
| $1.16M | 1.09% |
19,391
-90
| -0.5% | -$5.38K |
|
21
CVS Health
CVS
$92.8B
| $1.16M | 1.09% |
25,730
-14,800
| -37% | -$664K |
|
22
Microsoft
MSFT
$3.77T
| $1.13M | 1.07% |
2,687
+78
| +3% | +$32.9K |
|
23
Diageo
DEO
$62.1B
| $1.12M | 1.06% |
8,809
+2,804
| +47% | +$356K |
|
24
Exxon Mobil
XOM
$487B
| $1.04M | 0.98% |
9,661
-807
| -8% | -$86.8K |
|
|
25
Merck
MRK
$210B
| $1.02M | 0.96% |
10,234
+6,623
| +183% | +$659K |
|